Phathom Pharmaceuticals (PHAT) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.47
-1.3
-1.12
-0.95

Details

Expected EPS
-0.95
Actual EPS
-1.05
Surprise EPS
-0.1
Surprise Percent
+10.53%

Description

Phathom Pharmaceuticals (PHAT) has reported earnings of -1.05 per share for Q3 2025.

0 Comments

Share your thoughts